BreatheRxS (Deseret Biologicals, Inc.)


Welcome to the PulseAid listing for the Breathe drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc.
NON-PROPRIETARY NAME: Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Natrum Muriaticum, Rhus Tox, Sulphur, Adenosinum Cyclophosphoricum, Coenzyme A, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Lung (Sui
SUBSTANCE NAME: ACONITUM NAPELLUS; SILVER NITRATE; ARSENIC TRIOXIDE; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF; SULFUR; ADENOSINE CYCLIC PHOSPHATE; COENZYME A; SUS SCROFA UMBILICAL CORD; SUS SCROFA ADRENAL GLAND;
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-03-11
END MARKETING DATE: 2021-02-03


Breathe RxS HUMAN OTC DRUG Details:

Item DescriptionBreathe RxS from Deseret Biologicals, Inc.
LABELER NAME: Deseret Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6; 6; 10; 10; 10; 10; 10; 10; 10; 6; 6; 15; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2014-03-11
END MARKETING DATE: 2021-02-03
PRODUCT ID: 43742-0452_a3e8eefd-f532-49b5-9f47-74578e49ee1c
PRODUCT NDC: 43742-0452
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; SILVER NITRATE; ARSENIC TRIOXIDE; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF; SULFUR; ADENOSINE CYCLIC PHOSPHATE; COENZYME A; SUS SCROFA UMBILICAL CORD; SUS SCROFA ADRENAL GLAND; Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Breathe